Xiromerisiou G - Search Results

1

Large-scale assessment of polyglutamine repeat expansions in Parkinson disease.

Wang L, Aasly JO, Annesi G, Bardien S, Bozi M, Brice A, Carr J, Chung SJ, Clarke C, Crosiers D, Deutschländer A, Eckstein G, Farrer MJ, Goldwurm S, Garraux G, Hadjigeorgiou GM, Hicks AA, Hattori N, Klein C, Jeon B, Kim YJ, Lesage S, Lin JJ, Lynch T, Lichtner P, Lang AE, Mok V, Jasinska-Myga B, Mellick GD, Morrison KE, Opala G, Pihlstrøm L, Pramstaller PP, Park SS, Quattrone A, Rogaeva E, Ross OA, Stefanis L, Stockton JD, Silburn PA, Theuns J, Tan EK, Tomiyama H, Toft M, Van Broeckhoven C, Uitti RJ, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Yueh KC, Zhao Y, Gasser T, Maraganore DM, Krüger R, Sharma M; GEO-PD Consortium. Wang L, et al. Among authors: xiromerisiou g. Neurology. 2015 Oct 13;85(15):1283-92. doi: 10.1212/WNL.0000000000002016. Epub 2015 Sep 9. Neurology. 2015. PMID: 26354989 Free PMC article.

2

Single OnabotulinumtoxinA Session Add-On to Carbamazepine or Oxcarbazepine in Treatment-Refractory Trigeminal Neuralgia: A Case Series with 24-Week Follow Up.

Xiromerisiou G, Lampropoulos IC, Dermitzakis EV, Vikelis M, Marogianni C, Mysiris D, Argyriou AA. Xiromerisiou G, et al. Toxins (Basel). 2023 Aug 31;15(9):539. doi: 10.3390/toxins15090539. Toxins (Basel). 2023. PMID: 37755965 Free PMC article.

3

Predictors of Response to Fremanezumab in Migraine Patients with at Least Three Previous Preventive Failures: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry.

Argyriou AA, Dermitzakis EV, Xiromerisiou G, Rallis D, Soldatos P, Litsardopoulos P, Vikelis M. Argyriou AA, et al. Among authors: xiromerisiou g. J Clin Med. 2023 Apr 29;12(9):3218. doi: 10.3390/jcm12093218. J Clin Med. 2023. PMID: 37176658 Free PMC article.

4

Effects of Fremanezumab on Psychiatric Comorbidities in Difficult-to-Treat Patients with Chronic Migraine: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry.

Vikelis M, Dermitzakis EV, Xiromerisiou G, Rallis D, Soldatos P, Litsardopoulos P, Rikos D, Argyriou AA. Vikelis M, et al. Among authors: xiromerisiou g. J Clin Med. 2023 Jul 6;12(13):4526. doi: 10.3390/jcm12134526. J Clin Med. 2023. PMID: 37445560 Free PMC article.

5

IL-1RN and IL-1B gene polymorphisms and cerebral hemorrhagic events after traumatic brain injury.

Hadjigeorgiou GM, Paterakis K, Dardiotis E, Dardioti M, Aggelakis K, Tasiou A, Xiromerisiou G, Komnos A, Zintzaras E, Scarmeas N, Papadimitriou A, Karantanas A. Hadjigeorgiou GM, et al. Among authors: xiromerisiou g. Neurology. 2005 Oct 11;65(7):1077-82. doi: 10.1212/01.wnl.0000178890.93795.0e. Neurology. 2005. PMID: 16217062

6

Association of alpha-synuclein Rep1 polymorphism and Parkinson's disease: influence of Rep1 on age at onset.

Hadjigeorgiou GM, Xiromerisiou G, Gourbali V, Aggelakis K, Scarmeas N, Papadimitriou A, Singleton A. Hadjigeorgiou GM, et al. Among authors: xiromerisiou g. Mov Disord. 2006 Apr;21(4):534-9. doi: 10.1002/mds.20752. Mov Disord. 2006. PMID: 16250025

7

The human prion gene M129V polymorphism is not associated with idiopathic Parkinson's disease in three distinct populations.

Scholz SW, Xiromerisiou G, Fung HC, Eerola J, Hellström O, Papadimitriou A, Hadjigeorgiou GM, Tienari PJ, Fernandez HH, Mandel R, Okun MS, Gwinn-Hardy K, Singleton AB. Scholz SW, et al. Among authors: xiromerisiou g. Neurosci Lett. 2006 Mar 13;395(3):227-9. doi: 10.1016/j.neulet.2005.10.081. Epub 2005 Nov 18. Neurosci Lett. 2006. PMID: 16298483

8

Testing association between LRRK2 and Parkinson's disease and investigating linkage disequilibrium.

Paisán-Ruíz C, Evans EW, Jain S, Xiromerisiou G, Gibbs JR, Eerola J, Gourbali V, Hellström O, Duckworth J, Papadimitriou A, Tienari PJ, Hadjigeorgiou GM, Singleton AB. Paisán-Ruíz C, et al. Among authors: xiromerisiou g. J Med Genet. 2006 Feb;43(2):e9. doi: 10.1136/jmg.2005.036889. J Med Genet. 2006. PMID: 16467219 Free PMC article.

9

Screening for SNCA and LRRK2 mutations in Greek sporadic and autosomal dominant Parkinson's disease: identification of two novel LRRK2 variants.

Xiromerisiou G, Hadjigeorgiou GM, Gourbali V, Johnson J, Papakonstantinou I, Papadimitriou A, Singleton AB. Xiromerisiou G, et al. Eur J Neurol. 2007 Jan;14(1):7-11. doi: 10.1111/j.1468-1331.2006.01551.x. Eur J Neurol. 2007. PMID: 17222106

10

BDNF tagging polymorphisms and haplotype analysis in sporadic Parkinson's disease in diverse ethnic groups.

Xiromerisiou G, Hadjigeorgiou GM, Eerola J, Fernandez HH, Tsimourtou V, Mandel R, Hellström O, Gwinn-Hardy K, Okun MS, Tienari PJ, Singleton AB. Xiromerisiou G, et al. Neurosci Lett. 2007 Mar 19;415(1):59-63. doi: 10.1016/j.neulet.2006.12.038. Epub 2006 Dec 30. Neurosci Lett. 2007. PMID: 17229524

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

124 results

Search Page